Personal tools

Difference between revisions of "DOID:305"

From FANTOM5_SSTAR

Jump to: navigation, search
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
 
{{DOID
 
{{DOID
|id=DOID:305
+
|alt_id=DOID:2428;;DOID:6570
|name=carcinoma
 
|namespace=disease_ontology
 
|def="A cell type cancer that has_material_basis_in abnormally proliferating cells derived_from epithelial cells." [url:http://en.wikipedia.org/wiki/Carcinoma]
 
|xref=MSH:D002277;;NCI:C2916;;SNOMEDCT_2010_1_31:118285006;;SNOMEDCT_2010_1_31:134207000;;SNOMEDCT_2010_1_31:154433003;;SNOMEDCT_2010_1_31:188083002;;SNOMEDCT_2010_1_31:189546004;;SNOMEDCT_2010_1_31:189549006;;SNOMEDCT_2010_1_31:189559007;;SNOMEDCT_2010_1_31:269513004;;SNOMEDCT_2010_1_31:68453008;;SNOMEDCT_2010_1_31:71298006;;UMLS_CUI:C0007097;;UMLS_CUI:C0553707;;UMLS_CUI:C1368683
 
|is_a=DOID:0050687
 
|synonym="carcinoma" EXACT [CSP2005:2000-1867];;"epithelioma" EXACT [CSP2005:2000-5801];;"Epithelioma, malignant (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:71298006];;"malignant Epithelioma" EXACT [NCI2004_11_17:C6927];;"malignant epithelioma" EXACT []
 
 
|comment=
 
|comment=
|alt_id=DOID:2428;;DOID:6570
 
|disjoint_from=
 
|union_of=
 
 
|created_by=
 
|created_by=
|obo_creation_date=
+
|def="A cell type cancer that has_material_basis_in abnormally proliferating cells derived_from epithelial cells." [url:http://en.wikipedia.org/wiki/Carcinoma]
|subset=
 
 
|derives_from=
 
|derives_from=
 
|develops_from=
 
|develops_from=
 +
|disjoint_from=
 
|has_quality=
 
|has_quality=
 +
|id=DOID:305
 +
|is_a=DOID:0050687
 +
|is_obsolete=
 
|located_in=
 
|located_in=
 +
|name=carcinoma
 +
|namespace=FANTOM
 +
|obo_creation_date=
 
|part_of=
 
|part_of=
 +
|preceded_by=
 
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
 
|property_value=IAO:0000412 file:/Users/cjm/Dropbox/fantom5/HumanDO.obo
|is_obsolete=
+
|subset=
|preceded_by=
+
|synonym="carcinoma" EXACT [CSP2005:2000-1867];;"epithelioma" EXACT [CSP2005:2000-5801];;"Epithelioma, malignant (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:71298006];;"malignant Epithelioma" EXACT [NCI2004_11_17:C6927];;"malignant epithelioma" EXACT []
 +
|union_of=
 +
|xref=MSH:D002277;;NCI:C2916;;SNOMEDCT_2010_1_31:118285006;;SNOMEDCT_2010_1_31:134207000;;SNOMEDCT_2010_1_31:154433003;;SNOMEDCT_2010_1_31:188083002;;SNOMEDCT_2010_1_31:189546004;;SNOMEDCT_2010_1_31:189549006;;SNOMEDCT_2010_1_31:189559007;;SNOMEDCT_2010_1_31:269513004;;SNOMEDCT_2010_1_31:68453008;;SNOMEDCT_2010_1_31:71298006;;UMLS_CUI:C0007097;;UMLS_CUI:C0553707;;UMLS_CUI:C1368683
 
}}
 
}}

Latest revision as of 07:50, 12 September 2014

Name:carcinoma
Namespace:FANTOM
Definition:"A cell type cancer that has_material_basis_in abnormally proliferating cells derived_from epithelial cells." [url:http://en.wikipedia.org/wiki/Carcinoma]
Xrefs:
links:

MSH:D002277
NCI:C2916
SNOMEDCT_2010_1_31:118285006
SNOMEDCT_2010_1_31:134207000
SNOMEDCT_2010_1_31:154433003
SNOMEDCT_2010_1_31:188083002
SNOMEDCT_2010_1_31:189546004
SNOMEDCT_2010_1_31:189549006
SNOMEDCT_2010_1_31:189559007
SNOMEDCT_2010_1_31:269513004
SNOMEDCT_2010_1_31:68453008
SNOMEDCT_2010_1_31:71298006
UMLS_CUI:C0007097
UMLS_CUI:C0553707

UMLS_CUI:C1368683
Synonyms: "carcinoma" EXACT [CSP2005:2000-1867]
"epithelioma" EXACT [CSP2005:2000-5801]
"Epithelioma, malignant (morphologic abnormality)" EXACT [SNOMEDCT_2005_07_31:71298006]
"malignant Epithelioma" EXACT [NCI2004_11_17:C6927]
"malignant epithelioma" EXACT []
Alt_id: DOID:2428
DOID:6570

Ontology association<br>Each term has an is_a parent in the Disease Ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to DISEASE ontologies.<br><br>link to ontology dataset<br>data


Parents

is_a:DOID:0050687(cell type cancer)



Children


is a:DOID:1749 (squamous cell carcinoma),DOID:2671 (transitional cell carcinoma),DOID:299 (adenocarcinoma),DOID:5662 (pleomorphic carcinoma)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples

Human (Homo sapiens)

... further results Mouse (Mus musculus)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with DOID:305 (carcinoma), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data


P-valueFFCPShort description
2.94e-66FFCP PHASE1:Hg19::chr8:120221345..120221393,+#_e480e569f91ec859ccc67477be22025ep3@MAL2
2.94e-66FFCP PHASE2:Hg19::chr8:120221345..120221393,+#_e480e569f91ec859ccc67477be22025ep3@MAL2
9.17e-60FFCP PHASE1:Hg19::chr12:20975472..20975489,+#_fcb0c02bd1e339b5688b0e10779dba35p@chr12:20975472..20975489, +
9.17e-60FFCP PHASE2:Hg19::chr12:20975472..20975489,+#_fcb0c02bd1e339b5688b0e10779dba35p@chr12:20975472..20975489, +
6.95e-59FFCP PHASE2:Hg19::chr12:20975516..20975562,+#_bdfa9473d5032d75d03713599aca4f37p@chr12:20975516..20975562, +
6.95e-59FFCP PHASE1:Hg19::chr12:20975516..20975562,+#_bdfa9473d5032d75d03713599aca4f37p@chr12:20975516..20975562, +
2.8e-56FFCP PHASE1:Hg19::chr7:1595871..1595896,-#_71d7cc501bf27d8001283a623322f3ecp5@TMEM184A
2.8e-56FFCP PHASE2:Hg19::chr7:1595871..1595896,-#_71d7cc501bf27d8001283a623322f3ecp5@TMEM184A
2.92e-53FFCP PHASE1:Hg19::chr7:1595831..1595858,-#_878af2c488301f49eada36c0e8b5afd0p1@TMEM184A
2.92e-53FFCP PHASE2:Hg19::chr7:1595831..1595858,-#_878af2c488301f49eada36c0e8b5afd0p1@TMEM184A
8.91e-53FFCP PHASE1:Hg19::chr7:1595804..1595828,-#_d845ef4132d88c5f07cadd26d32f2c9fp3@TMEM184A
8.91e-53FFCP PHASE2:Hg19::chr7:1595804..1595828,-#_d845ef4132d88c5f07cadd26d32f2c9fp3@TMEM184A
1.09e-51FFCP PHASE1:Hg19::chr3:194040598..194040638,-#_7c92ddf661dc715e4a604608f6386aa1p@chr3:194040598..194040638, -
1.09e-51FFCP PHASE2:Hg19::chr3:194040598..194040638,-#_7c92ddf661dc715e4a604608f6386aa1p@chr3:194040598..194040638, -
1.28e-51FFCP PHASE1:Hg19::chr8:120221313..120221336,+#_7e8f458d77c9783e1f62002c0d68a125p5@MAL2
1.28e-51FFCP PHASE2:Hg19::chr8:120221313..120221336,+#_7e8f458d77c9783e1f62002c0d68a125p5@MAL2
3.28e-51FFCP PHASE1:Hg19::chr2:174562443..174562467,+#_af57c25d778f6f7ebab0f0600bea7112p@chr2:174562443..174562467, +
3.28e-51FFCP PHASE2:Hg19::chr2:174562443..174562467,+#_af57c25d778f6f7ebab0f0600bea7112p@chr2:174562443..174562467, +
5.99e-49FFCP PHASE2:Hg19::chr14:38064429..38064486,-#_20ded271638bde6fa09fa1ff34d51927p1@FOXA1
5.99e-49FFCP PHASE1:Hg19::chr14:38064429..38064486,-#_20ded271638bde6fa09fa1ff34d51927p1@FOXA1
1.76e-48FFCP PHASE1:Hg19::chr17:62770351..62770363,-#_9f6f90c81ff99c6ed20874b40bb98d77p@chr17:62770351..62770363, -
1.76e-48FFCP PHASE2:Hg19::chr17:62770351..62770363,-#_9f6f90c81ff99c6ed20874b40bb98d77p@chr17:62770351..62770363, -
2.63e-48FFCP PHASE1:Hg19::chr3:180707436..180707451,-#_375c94b527e250eb5d0456f0aca98093p2@DNAJC19
2.63e-48FFCP PHASE2:Hg19::chr3:180707436..180707451,-#_375c94b527e250eb5d0456f0aca98093p2@DNAJC19
2.8e-48FFCP PHASE2:Hg19::chr13:109917833..109917866,+#_049233a4db39cac49b7151a7bd4367bcp@chr13:109917833..109917866, +
2.8e-48FFCP PHASE1:Hg19::chr13:109917833..109917866,+#_049233a4db39cac49b7151a7bd4367bcp@chr13:109917833..109917866, +
3.23e-48FFCP PHASE2:Hg19::chr22:46022320..46022366,-#_a95c39af65aa24fc15fdbcae1992e6a8p@chr22:46022320..46022366, -
3.23e-48FFCP PHASE1:Hg19::chr22:46022320..46022366,-#_a95c39af65aa24fc15fdbcae1992e6a8p@chr22:46022320..46022366, -
3.94e-47FFCP PHASE1:Hg19::chr2:54784868..54784919,+#_021dec0a050cd2ca35da1c228f95d518p@chr2:54784868..54784919, +
3.94e-47FFCP PHASE2:Hg19::chr2:54784868..54784919,+#_021dec0a050cd2ca35da1c228f95d518p@chr2:54784868..54784919, +
4.99e-47FFCP PHASE2:Hg19::chr15:56311466..56311511,+#_1f47ea5a32af89e31db11ae26e4bd5c3p@chr15:56311466..56311511, +
4.99e-47FFCP PHASE1:Hg19::chr15:56311466..56311511,+#_1f47ea5a32af89e31db11ae26e4bd5c3p@chr15:56311466..56311511, +
6.38e-47FFCP PHASE1:Hg19::chr1:201979743..201979762,+#_13f3578cd46f9b4bbaa2cdb2d12cd4e1p1@ELF3
6.38e-47FFCP PHASE2:Hg19::chr1:201979743..201979762,+#_13f3578cd46f9b4bbaa2cdb2d12cd4e1p1@ELF3
9.96e-47FFCP PHASE2:Hg19::chr12:52585765..52585777,-#_efa21879bce925e5595dbaace2b67314p2@KRT80
9.96e-47FFCP PHASE1:Hg19::chr12:52585765..52585777,-#_efa21879bce925e5595dbaace2b67314p2@KRT80
3.03e-46FFCP PHASE2:Hg19::chr8:120255687..120255760,+#_0eb69a148f501989b2385c7c3def1068p4@MAL2
3.03e-46FFCP PHASE1:Hg19::chr8:120255687..120255760,+#_0eb69a148f501989b2385c7c3def1068p4@MAL2
5.42e-46FFCP PHASE1:Hg19::chr17:43503012..43503035,-#_55a87ec3d200160bedf51b4acb7e66b4p4@ARHGAP27
5.42e-46FFCP PHASE2:Hg19::chr17:43503012..43503035,-#_55a87ec3d200160bedf51b4acb7e66b4p4@ARHGAP27
1.07e-45FFCP PHASE1:Hg19::chr7:101917482..101917507,+#_59ca8e45a1711fd4f1d1d3a081ba3d4cp6@CUX1
1.07e-45FFCP PHASE2:Hg19::chr7:101917482..101917507,+#_59ca8e45a1711fd4f1d1d3a081ba3d4cp6@CUX1
1.42e-45FFCP PHASE1:Hg19::chr8:82644562..82644654,-#_508267ec1f3070b233f7c0115aa02cacp2@ZFAND1
1.42e-45FFCP PHASE2:Hg19::chr8:82644562..82644654,-#_508267ec1f3070b233f7c0115aa02cacp2@ZFAND1
2.28e-45FFCP PHASE1:Hg19::chr7:156803329..156803362,-#_39341b5cc32859293639d51a7ed0c4d2p1@MNX1
2.28e-45FFCP PHASE2:Hg19::chr7:156803329..156803362,-#_39341b5cc32859293639d51a7ed0c4d2p1@MNX1
2.88e-45FFCP PHASE1:Hg19::chr19:751122..751139,+#_dbd6dd1ac90a2099b1b6493b61a48ab9p1@C19orf21
2.88e-45FFCP PHASE2:Hg19::chr19:751122..751139,+#_dbd6dd1ac90a2099b1b6493b61a48ab9p1@C19orf21
1.72e-44FFCP PHASE1:Hg19::chr18:47376197..47376227,-#_133d5611df0592e4ad194f9ec3bd6718p2@MYO5B
1.72e-44FFCP PHASE2:Hg19::chr18:47376197..47376227,-#_133d5611df0592e4ad194f9ec3bd6718p2@MYO5B
2.93e-44FFCP PHASE1:Hg19::chr7:101917447..101917479,+#_b22ba3a60cf2998eaf25e2cfa7d60084p4@CUX1
2.93e-44FFCP PHASE2:Hg19::chr7:101917447..101917479,+#_b22ba3a60cf2998eaf25e2cfa7d60084p4@CUX1
1.26e-43FFCP PHASE1:Hg19::chr2:238499725..238499747,-#_24fd32b30a2a87f657a6f0bdf2bfa41dp2@RAB17
1.26e-43FFCP PHASE2:Hg19::chr2:238499725..238499747,-#_24fd32b30a2a87f657a6f0bdf2bfa41dp2@RAB17
1.31e-43FFCP PHASE2:Hg19::chr8:144821696..144821778,+#_cdea6a11277b81b841725508db2f0083p@chr8:144821696..144821778, +
1.31e-43FFCP PHASE1:Hg19::chr8:144821696..144821778,+#_cdea6a11277b81b841725508db2f0083p@chr8:144821696..144821778, +
1.5e-43FFCP PHASE2:Hg19::chr2:32264532..32264584,-#_4d1f41d3be2d66731677b437d1f45cefp@chr2:32264532..32264584, -
1.5e-43FFCP PHASE1:Hg19::chr2:32264532..32264584,-#_4d1f41d3be2d66731677b437d1f45cefp@chr2:32264532..32264584, -
3.61e-43FFCP PHASE1:Hg19::chr19:751104..751121,+#_5b2c8139a3dbdeed10de8b692c1346d2p2@C19orf21
3.61e-43FFCP PHASE2:Hg19::chr19:751104..751121,+#_5b2c8139a3dbdeed10de8b692c1346d2p2@C19orf21
4.96e-43FFCP PHASE1:Hg19::chr1:45988542..45988573,-#_041d87225f7d7b940e5002a8b4cb209cp2@PRDX1
4.96e-43FFCP PHASE2:Hg19::chr1:45988542..45988573,-#_041d87225f7d7b940e5002a8b4cb209cp2@PRDX1
7.6e-43FFCP PHASE2:Hg19::chr11:66139128..66139152,-#_0e5d62a735fe011282d84870a8be52a5p3@SLC29A2
7.6e-43FFCP PHASE1:Hg19::chr11:66139128..66139152,-#_0e5d62a735fe011282d84870a8be52a5p3@SLC29A2
1.26e-42FFCP PHASE2:Hg19::chr11:66139068..66139120,-#_4d8a36590aad95a87ed708df3a2c5d52p2@SLC29A2
1.26e-42FFCP PHASE1:Hg19::chr11:66139068..66139120,-#_4d8a36590aad95a87ed708df3a2c5d52p2@SLC29A2
1.76e-42FFCP PHASE1:Hg19::chr8:82644522..82644557,-#_f39c194436783e991b1b9a4bc74956fap4@ZFAND1
1.76e-42FFCP PHASE2:Hg19::chr8:82644522..82644557,-#_f39c194436783e991b1b9a4bc74956fap4@ZFAND1
3.06e-42FFCP PHASE2:Hg19::chr13:114103443..114103479,-#_3849c4e9bfdd0ab1c3f25154664844f0p2@ADPRHL1
3.06e-42FFCP PHASE1:Hg19::chr13:114103443..114103479,-#_3849c4e9bfdd0ab1c3f25154664844f0p2@ADPRHL1
3.8e-42FFCP PHASE2:Hg19::chr12:50419141..50419170,-#_e10f6273148938f42a15f4c0a71686d5p2@RACGAP1
3.8e-42FFCP PHASE1:Hg19::chr12:50419141..50419170,-#_e10f6273148938f42a15f4c0a71686d5p2@RACGAP1
5.75e-42FFCP PHASE1:Hg19::chr1:45988484..45988500,-#_8f7f788782bd8345ddfdfc9dac03b113p4@PRDX1
5.75e-42FFCP PHASE2:Hg19::chr1:45988484..45988500,-#_8f7f788782bd8345ddfdfc9dac03b113p4@PRDX1
6.17e-42FFCP PHASE1:Hg19::chr16:68260798..68260800,-#_0033052dcadf7cda6a30dc03d05d7ac7p@chr16:68260798..68260800, -
6.17e-42FFCP PHASE2:Hg19::chr16:68260798..68260800,-#_0033052dcadf7cda6a30dc03d05d7ac7p@chr16:68260798..68260800, -
8.38e-42FFCP PHASE1:Hg19::chr2:47596330..47596380,+#_d4789da7446258fa924a548023761e05p2@EPCAM
8.38e-42FFCP PHASE2:Hg19::chr2:47596330..47596380,+#_d4789da7446258fa924a548023761e05p2@EPCAM
1.09e-41FFCP PHASE1:Hg19::chr7:101917407..101917443,+#_9f587f8983e8c99fa7377c6746c55182p3@CUX1
1.09e-41FFCP PHASE2:Hg19::chr7:101917407..101917443,+#_9f587f8983e8c99fa7377c6746c55182p3@CUX1
1.15e-41FFCP PHASE1:Hg19::chr2:47596394..47596400,+#_773a3f3f2127c58d7291e7c3f21671d9p6@EPCAM
1.15e-41FFCP PHASE2:Hg19::chr2:47596394..47596400,+#_773a3f3f2127c58d7291e7c3f21671d9p6@EPCAM
2.08e-41FFCP PHASE1:Hg19::chr3:53033328..53033357,-#_2830df919bce7af41e737d3220e67913p@chr3:53033328..53033357, -
2.08e-41FFCP PHASE2:Hg19::chr3:53033328..53033357,-#_2830df919bce7af41e737d3220e67913p@chr3:53033328..53033357, -
3.43e-41FFCP PHASE1:Hg19::chr8:82644655..82644687,-#_209e65b69087ec47e4d1c2f9017e6aa8p3@ZFAND1
3.43e-41FFCP PHASE2:Hg19::chr8:82644655..82644687,-#_209e65b69087ec47e4d1c2f9017e6aa8p3@ZFAND1
4.76e-41FFCP PHASE1:Hg19::chr1:201979703..201979721,+#_c845bbb7cd42f7de1946ff5842214d39p2@ELF3
4.76e-41FFCP PHASE2:Hg19::chr1:201979703..201979721,+#_c845bbb7cd42f7de1946ff5842214d39p2@ELF3
5.39e-41FFCP PHASE1:Hg19::chr8:82644741..82644791,+#_72b918b3f4449aaf7b4235608d9ec8b3p2@CHMP4C
5.39e-41FFCP PHASE2:Hg19::chr8:82644741..82644791,+#_72b918b3f4449aaf7b4235608d9ec8b3p2@CHMP4C
5.49e-41FFCP PHASE1:Hg19::chr9:98189097..98189118,-#_3c510afd328e6f8c5c96ba46f3aeca25p1@ENST00000433644
5.49e-41FFCP PHASE2:Hg19::chr9:98189097..98189118,-#_3c510afd328e6f8c5c96ba46f3aeca25p1@ENST00000433644
5.55e-41FFCP PHASE1:Hg19::chr8:120220561..120220650,+#_b14553df922e9ba1cd04f08e03e13a6ap1@MAL2
5.55e-41FFCP PHASE2:Hg19::chr8:120220561..120220650,+#_b14553df922e9ba1cd04f08e03e13a6ap1@MAL2
9.06e-41FFCP PHASE1:Hg19::chr11:394196..394258,+#_ed107df516962fe3412fc56857d65ee8p1@PKP3
9.06e-41FFCP PHASE2:Hg19::chr11:394196..394258,+#_ed107df516962fe3412fc56857d65ee8p1@PKP3
1.5e-40FFCP PHASE1:Hg19::chr1:204347256..204347303,-#_bd22e27dc3669415f0655fd16c55f3d2p1@ENST00000441225
1.5e-40FFCP PHASE2:Hg19::chr1:204347256..204347303,-#_bd22e27dc3669415f0655fd16c55f3d2p1@ENST00000441225
1.69e-40FFCP PHASE1:Hg19::chr22:46373034..46373058,-#_e23edd540ad05e56280a1503f3ff1ac9p1@WNT7B
1.69e-40FFCP PHASE2:Hg19::chr22:46373034..46373058,-#_e23edd540ad05e56280a1503f3ff1ac9p1@WNT7B